| Revided Admission Date | |
| | |
|
THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A BREACH OF THE RELEVANT SECURITIES LAWS OF SUCH JURISDICTION.
Further to the announcement of 23 June 2015, EMED announces that admission to trading on AIM of the 2,060,520,685 New Ordinary Shares to be issued pursuant to the Capital Raising and the Capitalisation Issue is now expected to occur at 8.00 a.m. (BST) on 25 June 2015.
Enquiries
EMED Roger Davey/Alberto Lavandeira +34 959 59 28 50
Canaccord Genuity Limited (Corporate Broking) Henry Fitzgerald-O'Connor/Oliver Donaldson +44 207 523 8000
Brandon Hill Capital Oliver Stansfield +44 203 463 5061
Walbrook PR Nick Rome +44 207 933 8783
|
|
|
EMED Mining Public Ltd
|
|
DEVELOPMENT STAGE |
|
CODE : EMED.L |
|
ISIN : CY0000100319 |
|
|
| |
ProfileMarket
IndicatorsVALUE :
Projects & res.Press
releasesAnnual
reportRISK :
Asset profileContact Cpy |
EMED is a gold and copper development stage company based in Cyprus. EMED develops gold, copper and zinc in Cyprus and in Spain, and holds various exploration projects in Cyprus. Its main assets in development are PROYECTO RIO TINTO in Spain and KLIROU in Cyprus and its main exploration properties are DETVA, STIAVNICA-HODRUSA and BIELY VRCH in Slovakia and KLIROU in Cyprus. EMED is listed in United Kingdom. Its market capitalisation is GBX 54.7 billions as of today (US$ 65.5 billions, € 57.4 billions). Its stock quote reached its lowest recent point on September 18, 2015 at GBX 0.12, and its highest recent level on January 17, 2022 at GBX 404.00. EMED has 135 475 650 shares outstanding. |